US 12268660
Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension
granted A61KA61K31/167A61K31/216
Quick answer
US patent 12268660 (Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension) held by Aardvark Therapeutics, Inc. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aardvark Therapeutics, Inc.
- Grant date
- Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/167, A61K31/216, A61K45/06, A61P